Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met

<div>The effect of a combination of erlotinib and EHE (a) or combination of SU11274 and erlotinib (b) on the expression levels of c-Met, pMet, EGFR, and pEGFR. The expression levels of c-Met, pMet, EGFR, and pEGFR in H1993 cells at 4 h after treatment of erlotinib, EHE, SU11274, a combination of EHE and erlotinib, or a combination of SU11274 and erlotinib were analyzed by western blotting.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met 

Figure 3 | Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met 